Zobrazeno 1 - 10
of 419
pro vyhledávání: '"T, Papapetropoulos"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Spiridon Papapetropoulos, A. Papadimitriou, Aglaia Athanassiadou, T. Papapetropoulos, Christos Paschalis, John Ellul
Publikováno v:
European Journal of Neurology. 10:281-286
An Ala53Thr mutation of the alpha-synuclein has been recently identified as a rare cause of familial Parkinson's disease (fPD). In the present study, the clinical characteristics of Parkinson's disease (PD) patients with Ala53Thr alpha-synuclein muta
Autor:
T. Papapetropoulos, Dimitrios Dougenis, Dionysis S Bonikos, Athanassios C. Tsamandas, Stavroula Salakou
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 20:712-721
Objective: The aim of this study was to evaluate bcl-2, bax (apoptotic-oncoproteins), and Ki67 (cell proliferation-marker) expression in thymus of patients with myasthenia gravis (MG) and to determine the potential correlation with clinicopathologic
Autor:
Sternke‐Hoffmann, Rebecca1 (AUTHOR), Sun, Xun1 (AUTHOR), Menzel, Andreas2 (AUTHOR), Pinto, Miriam Dos Santos1 (AUTHOR), Venclovaite, Urte1 (AUTHOR), Wördehoff, Michael3 (AUTHOR), Hoyer, Wolfgang3 (AUTHOR), Zheng, Wenwei4 (AUTHOR) wenweizheng@asu.edu, Luo, Jinghui1 (AUTHOR) Jinghui.luo@psi.ch
Publikováno v:
Advanced Science. 9/11/2024, Vol. 11 Issue 34, p1-15. 15p.
Autor:
Chou, Shih‐Jie1,2 (AUTHOR), Yang, Yi‐Ping1,2 (AUTHOR), Chiang, Min‐Ren3 (AUTHOR), Chen, Chih‐Ying1,2 (AUTHOR), Lai, Henkie Isahwan Ahmad Mulyadi1,2,4 (AUTHOR), Lin, Yi‐Ying1,2 (AUTHOR), Wu, You‐Ren1,2 (AUTHOR), Wang, I‐Chieh1,2 (AUTHOR), Yarmishyn, Aliaksandr A.1,2 (AUTHOR), Chiou, Guang‐Yuh5,6 (AUTHOR), Lin, Tai‐Chi7,8 (AUTHOR), Hwang, De‐Kuang7,8 (AUTHOR), Chen, Shih‐Jen7,8 (AUTHOR), Chien, Yueh1,2 (AUTHOR) g39005005@gmail.com, Hu, Shang‐Hsiu3 (AUTHOR) shhu@mx.nthu.edu.tw, Chiou, Shih‐Hwa1,2,8,9 (AUTHOR) shchiou@vghtpe.gov.tw
Publikováno v:
Small Science. Aug2024, Vol. 4 Issue 8, p1-15. 15p.
COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals.
Autor:
de Souza Goncalves, Bruno1 (AUTHOR) desouzagonca@marshall.edu, Sangani, Darshan1 (AUTHOR) sangani4@marshall.edu, Nayyar, Aleen2 (AUTHOR) aleen.nayyar@gmail.com, Puri, Raghav1 (AUTHOR) puri1@marshall.edu, Irtiza, Mahir1 (AUTHOR) mahirirtiza07@gmail.com, Nayyar, Asma1 (AUTHOR) nayyara@marshall.edu, Khalyfa, Abdelnaby1 (AUTHOR) khalyfa@marshall.edu, Sodhi, Komal1 (AUTHOR) sodhi@marshall.edu, Pillai, Sneha S.1 (AUTHOR) pillais@marshall.edu
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8481. 39p.
Autor:
N G Beratis, D A Papanastasiou, A M Magiakou, D Papanicolaou, T Papapetropoulos, E Tzebelikos
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 54:997-1000
As some patients with beta-thalassaemia manifested neurological signs, clinical and electrophysiological investigations were carried out on 53 thalassaemic patients and 29 healthy control subjects. Twenty per cent of the patients showed clinical and
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 1:52-55
The hypothesis that head injuries and surgical anaesthetics might contribute to the risk of age-related cognitive impairment was tested in a prospective study of 103 patients with dementia of Alzheimer type (DAT), and 26 patients with multi-infarct d
Autor:
S, Papapetropoulos, J, Ellul, C, Paschalis, A, Athanassiadou, A, Papadimitriou, T, Papapetropoulos
Publikováno v:
European journal of neurology. 10(3)
An Ala53Thr mutation of the alpha-synuclein has been recently identified as a rare cause of familial Parkinson's disease (fPD). In the present study, the clinical characteristics of Parkinson's disease (PD) patients with Ala53Thr alpha-synuclein muta
Publikováno v:
Clinical Rheumatology. 13:586-588
Five patients out of 71 with rheumatoid arthritis (RA), who received D-penicillamine, developed myasthenia gravis (MG) within a two-year period. They all responded promptly to discontinuation of the drug and pyridostigmine administration. None of the